Literature DB >> 32588821

Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry.

Mohamed O Mohamed1, Jawed Polad, David Hildick-Smith, Olivier Bizeau, Ruslan K Baisebenov, Marco Roffi, Andrés Íñiguez-Romo, Bernard Chevalier, Clemens von Birgelen, Ariel Roguin, Adel Aminian, Michael Angioi, Mamas A Mamas.   

Abstract

AIMS: The present study sought to examine the prevalence, clinical characteristics and one-year outcomes of patients undergoing percutaneous coronary intervention (PCI) to complex lesions (multivessel PCI, ≥3 stents, ≥3 lesions, bifurcation with ≥2 stents, total stent length >60 mm or chronic total occlusion [CTO]) in a prospective multicentre registry. METHODS AND
RESULTS: Using the e-Ultimaster multicentre registry, a post hoc subgroup analysis was performed on 35,839 patients undergoing PCI, stratified by procedure complexity, and further by number and type of complex features. Overall, complex PCI patients (n=9,793, 27.3%) were older, more comorbid and were associated with an increased hazard ratio (HR) of the composite endpoint at one year (target lesion failure [TLF]: 1.41 [1.25; 1.59]), driven by an increased hazard of cardiac death (1.28 [1.05; 1.55]), target vessel myocardial infarction (1.48 [1.18; 1.86]) and clinically driven target lesion revascularisation. The hazard of complications increased with the rising number of complex features (3-6 vs 1-2 vs none) for all outcomes. All individual complex features were associated with an increased hazard of composite complications (except CTO) and definite/probable stent thrombosis.
CONCLUSIONS: Overall, complex PCI is associated with an increased risk of mortality and complications at one year. The number and types of complex features have differing impacts on long-term outcomes.

Entities:  

Mesh:

Year:  2020        PMID: 32588821     DOI: 10.4244/EIJ-D-20-00361

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.

Authors:  Rayyan Hemetsberger; Mohammad Abdelghani; Ralph Toelg; Hector M Garcia-Garcia; Serdar Farhan; Nader Mankerious; Karim Elbasha; Abdelhakim Allali; Stephan Windecker; Thierry Lefèvre; Shigeru Saito; David Kandzari; Ron Waksman; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2022-02-25       Impact factor: 5.460

2.  Contemporary approaches to bifurcation stenting.

Authors:  Claire E Raphael; Peter D O'Kane
Journal:  JRSM Cardiovasc Dis       Date:  2021-02-24

3.  Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy.

Authors:  Sheng-Wei Huang; Po-Wei Chen; Wen-Han Feng; I-Chang Hsieh; Ming-Yun Ho; Chung-Wei Cheng; Hung-I Yeh; Ching-Pei Chen; Wei-Chun Huang; Ching-Chang Fang; Hui-Wen Lin; Sheng-Hsiang Lin; Chin-Feng Tsai; Chun-Hung Su; Yi-Heng Li
Journal:  Front Cardiovasc Med       Date:  2022-02-24

4.  Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.

Authors:  Mohamed O Mohamed; Pablo Lamellas; Ariel Roguin; Rohit M Oemrawsingh; Alexander J J Ijsselmuiden; Helen Routledge; Frank van Leeuwen; Roxane Debrus; Marco Roffi; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

5.  Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study.

Authors:  Holger M Nef; Albrecht Elsässer; Helge Möllmann; Mohammed Abdel-Hadi; Timm Bauer; Martin Brück; Holger Eggebrecht; Joachim R Ehrlich; Markus W Ferrari; Stephan Fichtlscherer; Ulrich Hink; Hans Hölschermann; Rifat Kacapor; Oliver Koeth; Serguei Korboukov; Steffen Lamparter; Alexander J Laspoulas; Ralf Lehmann; Christoph Liebetrau; Tobias Plücker; Jörn Pons-Kühnemann; Volker Schächinger; Bernhard Schieffer; Peter Schott; Matthias Schulze; Claudius Teupe; Mariuca Vasa-Nicotera; Michael Weber; Christoph Weinbrenner; Gerald Werner; Christian W Hamm; Oliver Dörr
Journal:  Clin Res Cardiol       Date:  2020-11-21       Impact factor: 5.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.